Jul. 6, 2012 (China Knowledge) - Tianjin
Chase Sun Pharmaceutical Co Ltd<300026
> has announced that it expected its net profit to soar between130% and 160% YoY in the first half of this year.
The company said in a statement filed with the Shenzhen Stock Exchange
that its net profit was estimated at between RMB 99.22 million and RMB 112 million in the first six months.
The company attributed the strong growth in net profit to a significant increase in revenue from its major products and higher profit contribution from subsidiary Beijing
Kangrentang Pharmaceutical Co.
In the first quarter of this year, the company's net profit was RMB 38.01 million, up 95.85% from the same period of last year. Core business revenue surged 52.75% YoY to RMB 160.42 million in the period.